Cognitive impairment following TBI is found to be associated with the level of apolipoprotein E ε4 (ApoE-ε4), which reduces brain metabolism in the medial temporal and prefrontal lobe of TBI patients (Hellstrøm et al., 2022). This evidence concerns the gene APOE and Cognitive impairment.